Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances R Levin

Showing results (191-200 of 262) with videos related to

Pageof 27
Sort By:
The American Journal on Addictions|September 9, 2020
Advocacy and Public Policy Efforts of the American Academy of Addiction PsychiatryRichard N Rosenthal, Justine W Welsh, Hilary S Connery, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|January 20, 2021
The utility of a formative one-station objective structured clinical examination for Substance use disorders in a dental curriculumFolarin Odusola, Jennifer L Smith, Eva Turrigiano, et al.
Experimental and Clinical Psychopharmacology|February 26, 2016
Derived relations moderate the association between changes in the strength of commitment language and cocaine treatment responseKenneth M Carpenter, Paul C Amrhein, Krysten W Bold, et al.
The American Journal of Drug and Alcohol Abuse|June 7, 2021
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
JAMA Psychiatry|April 19, 2015
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical TrialFrances R Levin, John J Mariani, Sheila Specker, et al.
Psychiatric Services (Washington, D.C.)|August 9, 2021
Well-Being of Health Care Professionals Treating Opioid Use Disorder During the COVID-19 Pandemic: Results From a National SurveyDerek Blevins, Brandy F Henry, Minhee Sung, et al.
Preventive Medicine|May 5, 2023
Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York CityBennett Allen, Cale Basaraba, Thomas Corbeil, et al.
Experimental and Clinical Psychopharmacology|September 21, 2023
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trialKenneth M Carpenter, C Jean Choi, Cale Basaraba, et al.
Journal of Psychiatric Research|December 10, 2021
Pain catastrophizing and mental health phenotypes in adults with refractory chronic pain: A latent class analysisDeepika E Slawek, Madiha Syed, Chinazo O Cunningham, et al.
Contemporary Clinical Trials|April 10, 2021
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorderNikhil Seval, Cynthia A Frank, Alain H Litwin, et al.
Pageof 27

Showing results (191-200 of 262) with videos related to

Sort By:
Pageof 27
The American Journal on Addictions|September 9, 2020
Advocacy and Public Policy Efforts of the American Academy of Addiction PsychiatryRichard N Rosenthal, Justine W Welsh, Hilary S Connery, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|January 20, 2021
The utility of a formative one-station objective structured clinical examination for Substance use disorders in a dental curriculumFolarin Odusola, Jennifer L Smith, Eva Turrigiano, et al.
Experimental and Clinical Psychopharmacology|February 26, 2016
Derived relations moderate the association between changes in the strength of commitment language and cocaine treatment responseKenneth M Carpenter, Paul C Amrhein, Krysten W Bold, et al.
The American Journal of Drug and Alcohol Abuse|June 7, 2021
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
JAMA Psychiatry|April 19, 2015
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical TrialFrances R Levin, John J Mariani, Sheila Specker, et al.
Psychiatric Services (Washington, D.C.)|August 9, 2021
Well-Being of Health Care Professionals Treating Opioid Use Disorder During the COVID-19 Pandemic: Results From a National SurveyDerek Blevins, Brandy F Henry, Minhee Sung, et al.
Preventive Medicine|May 5, 2023
Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York CityBennett Allen, Cale Basaraba, Thomas Corbeil, et al.
Experimental and Clinical Psychopharmacology|September 21, 2023
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trialKenneth M Carpenter, C Jean Choi, Cale Basaraba, et al.
Journal of Psychiatric Research|December 10, 2021
Pain catastrophizing and mental health phenotypes in adults with refractory chronic pain: A latent class analysisDeepika E Slawek, Madiha Syed, Chinazo O Cunningham, et al.
Contemporary Clinical Trials|April 10, 2021
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorderNikhil Seval, Cynthia A Frank, Alain H Litwin, et al.
Pageof 27